

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 4.46587289 |
| 2 | protein maturation by protein folding (GO:0022417) | 4.26800573 |
| 3 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.17427072 |
| 4 | formation of translation preinitiation complex (GO:0001731) | 4.12754102 |
| 5 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.12118547 |
| 6 | chromatin assembly (GO:0031497) | 3.96021339 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 3.80620272 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.80620272 |
| 9 | regulation of translational termination (GO:0006449) | 3.78272094 |
| 10 | viral mRNA export from host cell nucleus (GO:0046784) | 3.69669510 |
| 11 | negative regulation of B cell apoptotic process (GO:0002903) | 3.47166388 |
| 12 | innate immune response in mucosa (GO:0002227) | 3.46621437 |
| 13 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.44187945 |
| 14 | ribosome assembly (GO:0042255) | 3.43267669 |
| 15 | peptidyl-arginine methylation (GO:0018216) | 3.36083692 |
| 16 | peptidyl-arginine N-methylation (GO:0035246) | 3.36083692 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32025675 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26870826 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.24430065 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23803825 |
| 21 | ribosome biogenesis (GO:0042254) | 3.22262326 |
| 22 | establishment of viral latency (GO:0019043) | 3.22054570 |
| 23 | DNA deamination (GO:0045006) | 3.20867689 |
| 24 | DNA strand elongation (GO:0022616) | 3.19615300 |
| 25 | histone arginine methylation (GO:0034969) | 3.11329129 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10063804 |
| 27 | establishment of integrated proviral latency (GO:0075713) | 3.05058776 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.98597763 |
| 29 | glomerular basement membrane development (GO:0032836) | 2.97511467 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 2.95852689 |
| 31 | positive regulation of prostaglandin secretion (GO:0032308) | 2.92896555 |
| 32 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.89195614 |
| 33 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.89195614 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87052425 |
| 35 | actin-myosin filament sliding (GO:0033275) | 2.86770804 |
| 36 | muscle filament sliding (GO:0030049) | 2.86770804 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77014858 |
| 38 | UTP biosynthetic process (GO:0006228) | 2.76282545 |
| 39 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.73518529 |
| 40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73325459 |
| 41 | skeletal muscle contraction (GO:0003009) | 2.72015839 |
| 42 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71829417 |
| 43 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71829417 |
| 44 | B cell mediated immunity (GO:0019724) | 2.69708892 |
| 45 | mucosal immune response (GO:0002385) | 2.67731550 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65815033 |
| 47 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.64889373 |
| 48 | antibacterial humoral response (GO:0019731) | 2.64191584 |
| 49 | base-excision repair (GO:0006284) | 2.61877480 |
| 50 | cellular response to interleukin-4 (GO:0071353) | 2.61726900 |
| 51 | proline biosynthetic process (GO:0006561) | 2.60268386 |
| 52 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.58250218 |
| 53 | muscle cell migration (GO:0014812) | 2.57799260 |
| 54 | mitochondrial RNA metabolic process (GO:0000959) | 2.56992607 |
| 55 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.56945560 |
| 56 | positive regulation of cell killing (GO:0031343) | 2.56538832 |
| 57 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.54913215 |
| 58 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.54396843 |
| 59 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.54396843 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 2.53937844 |
| 61 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.51688281 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.51688281 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.51688281 |
| 64 | pseudouridine synthesis (GO:0001522) | 2.51188251 |
| 65 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.50923050 |
| 66 | DNA replication initiation (GO:0006270) | 2.50323189 |
| 67 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.50061465 |
| 68 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.49068092 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.48716629 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 2.48164378 |
| 71 | AMP metabolic process (GO:0046033) | 2.46854580 |
| 72 | negative thymic T cell selection (GO:0045060) | 2.46362618 |
| 73 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.45742487 |
| 74 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.45580546 |
| 75 | UTP metabolic process (GO:0046051) | 2.44211126 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 2.44011805 |
| 77 | regulation of prostaglandin secretion (GO:0032306) | 2.43241457 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.42962341 |
| 79 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.42143863 |
| 80 | ribosomal large subunit biogenesis (GO:0042273) | 2.40814723 |
| 81 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.40692901 |
| 82 | regulation of B cell apoptotic process (GO:0002902) | 2.40598222 |
| 83 | ribosomal small subunit assembly (GO:0000028) | 2.40012566 |
| 84 | thymic T cell selection (GO:0045061) | 2.39721628 |
| 85 | GTP biosynthetic process (GO:0006183) | 2.39283286 |
| 86 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.38186552 |
| 87 | peptidyl-arginine modification (GO:0018195) | 2.38002378 |
| 88 | positive regulation of myotube differentiation (GO:0010831) | 2.37283523 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 2.36641471 |
| 90 | nuclear envelope reassembly (GO:0031468) | 2.36641471 |
| 91 | actin-mediated cell contraction (GO:0070252) | 2.36560845 |
| 92 | glycolytic process (GO:0006096) | 2.36540076 |
| 93 | positive thymic T cell selection (GO:0045059) | 2.36401524 |
| 94 | negative T cell selection (GO:0043383) | 2.36147076 |
| 95 | antimicrobial humoral response (GO:0019730) | 2.34675617 |
| 96 | rRNA processing (GO:0006364) | 2.34574072 |
| 97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.34166821 |
| 98 | negative regulation of ligase activity (GO:0051352) | 2.34166821 |
| 99 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.33884197 |
| 100 | regulation of protein heterodimerization activity (GO:0043497) | 2.33308553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.97987976 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.97100602 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34561074 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85228952 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74459200 |
| 6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63782133 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.58264963 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.56135987 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49311669 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.39289384 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35273839 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29457219 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25294457 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23232316 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20594138 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15224068 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05756739 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.05159168 |
| 19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.03581356 |
| 20 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 2.01660298 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96260413 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95151426 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.92789984 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.92273281 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89664890 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88707907 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86135079 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84959763 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80509330 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.79122083 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77453506 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77210825 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73085530 |
| 34 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.72164596 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70532572 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68977623 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68455686 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67245861 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66503373 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.65990001 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65652971 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.64278504 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63324835 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.62797222 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61531430 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60449215 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60294417 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.59864521 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55946691 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.55824456 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.53367753 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.51968610 |
| 53 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.48022737 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45611003 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44422269 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40072895 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36360928 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35554550 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34395754 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32761133 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32639315 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.32299286 |
| 63 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.31849950 |
| 64 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.29850803 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.27625546 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24989888 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23608389 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22001677 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20722777 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20284455 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20025824 |
| 72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19731063 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18891067 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16357638 |
| 75 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15756923 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14854841 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14618443 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13846977 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11439676 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11037995 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08893434 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08717932 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08217593 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07694430 |
| 85 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07600200 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05490605 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05295282 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04483504 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.03247215 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03115325 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00710738 |
| 92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98858389 |
| 93 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98782375 |
| 94 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96856353 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93364616 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93132443 |
| 97 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92600372 |
| 98 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.91130807 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90013678 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89778551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.43699525 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 2.92138538 |
| 3 | MP0002166_altered_tumor_susceptibility | 2.87101020 |
| 4 | MP0000685_abnormal_immune_system | 2.78007018 |
| 5 | MP0005671_abnormal_response_to | 2.64807810 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.60639634 |
| 7 | MP0004272_abnormal_basement_membrane | 2.46681510 |
| 8 | MP0002006_tumorigenesis | 2.41591482 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.33171843 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.19009638 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.18769056 |
| 12 | MP0000751_myopathy | 2.15515971 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.00460699 |
| 14 | MP0005275_abnormal_skin_tensile | 1.99407868 |
| 15 | MP0003693_abnormal_embryo_hatching | 1.96666501 |
| 16 | MP0003111_abnormal_nucleus_morphology | 1.89942041 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 1.82446131 |
| 18 | MP0001661_extended_life_span | 1.70930290 |
| 19 | MP0000749_muscle_degeneration | 1.70368005 |
| 20 | MP0003077_abnormal_cell_cycle | 1.67267033 |
| 21 | MP0002060_abnormal_skin_morphology | 1.62223718 |
| 22 | MP0001800_abnormal_humoral_immune | 1.57778831 |
| 23 | MP0000747_muscle_weakness | 1.56833509 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.55812516 |
| 25 | MP0002163_abnormal_gland_morphology | 1.51262652 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.50476528 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.47977280 |
| 28 | MP0003786_premature_aging | 1.46164015 |
| 29 | MP0000733_abnormal_muscle_development | 1.45765914 |
| 30 | MP0008058_abnormal_DNA_repair | 1.44544761 |
| 31 | MP0008007_abnormal_cellular_replicative | 1.42869760 |
| 32 | MP0002398_abnormal_bone_marrow | 1.42346326 |
| 33 | MP0001790_abnormal_immune_system | 1.42169505 |
| 34 | MP0005387_immune_system_phenotype | 1.42169505 |
| 35 | MP0005451_abnormal_body_composition | 1.41271685 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.39914116 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.34890276 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.30542010 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.28340706 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.27737574 |
| 41 | MP0000759_abnormal_skeletal_muscle | 1.26586040 |
| 42 | MP0002019_abnormal_tumor_incidence | 1.25145012 |
| 43 | MP0002723_abnormal_immune_serum | 1.24691371 |
| 44 | MP0001819_abnormal_immune_cell | 1.24110204 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.23949698 |
| 46 | MP0000490_abnormal_crypts_of | 1.19414327 |
| 47 | MP0002722_abnormal_immune_system | 1.18539739 |
| 48 | MP0001873_stomach_inflammation | 1.17133294 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.17033031 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.15486730 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.11565769 |
| 52 | MP0000716_abnormal_immune_system | 1.10464641 |
| 53 | MP0002429_abnormal_blood_cell | 1.09878074 |
| 54 | MP0000350_abnormal_cell_proliferation | 1.08898761 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.08369778 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.07583109 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.05650444 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.05422842 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.04069339 |
| 60 | MP0004134_abnormal_chest_morphology | 1.03661871 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.02852300 |
| 62 | MP0003878_abnormal_ear_physiology | 1.02852300 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.02792078 |
| 64 | MP0000613_abnormal_salivary_gland | 1.00578188 |
| 65 | MP0002269_muscular_atrophy | 0.99759108 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.97248270 |
| 67 | MP0001730_embryonic_growth_arrest | 0.96885787 |
| 68 | MP0002009_preneoplasia | 0.95941084 |
| 69 | MP0009785_altered_susceptibility_to | 0.93752782 |
| 70 | MP0003436_decreased_susceptibility_to | 0.93563807 |
| 71 | MP0008932_abnormal_embryonic_tissue | 0.92706017 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.92488310 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.91651586 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.91496772 |
| 75 | MP0009697_abnormal_copulation | 0.88679622 |
| 76 | MP0002106_abnormal_muscle_physiology | 0.86278106 |
| 77 | MP0005025_abnormal_response_to | 0.86177962 |
| 78 | MP0002102_abnormal_ear_morphology | 0.85119470 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.84990800 |
| 80 | MP0005330_cardiomyopathy | 0.84930958 |
| 81 | MP0000858_altered_metastatic_potential | 0.84757493 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.83465980 |
| 83 | MP0003045_fibrosis | 0.82154806 |
| 84 | MP0004510_myositis | 0.82028766 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.81485179 |
| 86 | MP0000358_abnormal_cell_content/ | 0.81117416 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.79324428 |
| 88 | MP0002080_prenatal_lethality | 0.79278229 |
| 89 | MP0001542_abnormal_bone_strength | 0.79188385 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.78816524 |
| 91 | MP0005165_increased_susceptibility_to | 0.76941735 |
| 92 | MP0000313_abnormal_cell_death | 0.76270805 |
| 93 | MP0005369_muscle_phenotype | 0.73879264 |
| 94 | MP0001243_abnormal_dermal_layer | 0.73304991 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.70500125 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.70103106 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.68873193 |
| 98 | MP0001849_ear_inflammation | 0.68131207 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.68126192 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.67693863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Distal arthrogryposis (HP:0005684) | 8.17305183 |
| 2 | Round ear (HP:0100830) | 6.09815064 |
| 3 | Trismus (HP:0000211) | 5.88698528 |
| 4 | Ulnar deviation of the wrist (HP:0003049) | 5.55206763 |
| 5 | Calcaneovalgus deformity (HP:0001848) | 5.25894352 |
| 6 | Deformed tarsal bones (HP:0008119) | 4.67410607 |
| 7 | Absent phalangeal crease (HP:0006109) | 4.59103089 |
| 8 | Breech presentation (HP:0001623) | 4.53043296 |
| 9 | Onycholysis (HP:0001806) | 4.15308645 |
| 10 | Abnormal finger flexion creases (HP:0006143) | 3.93865409 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 3.73454983 |
| 12 | Metatarsus adductus (HP:0001840) | 3.33759936 |
| 13 | Abnormality of the calcaneus (HP:0008364) | 3.30754313 |
| 14 | IgM deficiency (HP:0002850) | 3.19466769 |
| 15 | Malignant hyperthermia (HP:0002047) | 3.13070377 |
| 16 | IgA deficiency (HP:0002720) | 3.08253259 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.04095406 |
| 18 | Conical tooth (HP:0000698) | 2.90331925 |
| 19 | Premature rupture of membranes (HP:0001788) | 2.88565185 |
| 20 | Recurrent bronchitis (HP:0002837) | 2.83287612 |
| 21 | Nemaline bodies (HP:0003798) | 2.81452284 |
| 22 | Amniotic constriction ring (HP:0009775) | 2.76647424 |
| 23 | Abnormality of placental membranes (HP:0011409) | 2.76647424 |
| 24 | Chin dimple (HP:0010751) | 2.69013748 |
| 25 | IgG deficiency (HP:0004315) | 2.68478798 |
| 26 | Dry hair (HP:0011359) | 2.58529886 |
| 27 | Ridged nail (HP:0001807) | 2.55995589 |
| 28 | Lymphopenia (HP:0001888) | 2.54365449 |
| 29 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53273214 |
| 30 | Abnormal auditory evoked potentials (HP:0006958) | 2.48370387 |
| 31 | Progressive muscle weakness (HP:0003323) | 2.46547582 |
| 32 | Fetal akinesia sequence (HP:0001989) | 2.45070152 |
| 33 | Abnormal delivery (HP:0001787) | 2.43212580 |
| 34 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.40832362 |
| 35 | Aplasia of the musculature (HP:0100854) | 2.38375989 |
| 36 | Atrophic scars (HP:0001075) | 2.37477671 |
| 37 | Abnormal gallbladder physiology (HP:0012438) | 2.26751513 |
| 38 | Cholecystitis (HP:0001082) | 2.26751513 |
| 39 | Squamous cell carcinoma (HP:0002860) | 2.26651078 |
| 40 | Fragile skin (HP:0001030) | 2.24002787 |
| 41 | Hyperacusis (HP:0010780) | 2.21870384 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.14904167 |
| 43 | Emphysema (HP:0002097) | 2.12118060 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.12042704 |
| 45 | Chronic diarrhea (HP:0002028) | 2.08652138 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.06403309 |
| 47 | Popliteal pterygium (HP:0009756) | 2.06099512 |
| 48 | Erythema (HP:0010783) | 2.05001797 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.03886490 |
| 50 | Increased connective tissue (HP:0009025) | 2.03690373 |
| 51 | Adducted thumb (HP:0001181) | 2.02335912 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.01866583 |
| 53 | Cellulitis (HP:0100658) | 2.00467014 |
| 54 | Oral leukoplakia (HP:0002745) | 1.99605491 |
| 55 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.99312935 |
| 56 | Meningitis (HP:0001287) | 1.92593925 |
| 57 | J-shaped sella turcica (HP:0002680) | 1.92509863 |
| 58 | Entropion (HP:0000621) | 1.91557020 |
| 59 | Rough bone trabeculation (HP:0100670) | 1.90719036 |
| 60 | Type I transferrin isoform profile (HP:0003642) | 1.88801918 |
| 61 | Muscle fiber atrophy (HP:0100295) | 1.88690842 |
| 62 | Recurrent sinusitis (HP:0011108) | 1.88492256 |
| 63 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.88167365 |
| 64 | Vasculitis (HP:0002633) | 1.87285304 |
| 65 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.83737521 |
| 66 | Urticaria (HP:0001025) | 1.80315829 |
| 67 | Ureteral stenosis (HP:0000071) | 1.79837612 |
| 68 | Glucose intolerance (HP:0000833) | 1.79594754 |
| 69 | Exercise-induced myalgia (HP:0003738) | 1.77268083 |
| 70 | Abnormality of incisor morphology (HP:0011063) | 1.76853068 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 1.76456205 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74306480 |
| 73 | Myoglobinuria (HP:0002913) | 1.72150152 |
| 74 | Myopathic facies (HP:0002058) | 1.70914549 |
| 75 | Ureteral obstruction (HP:0006000) | 1.70474273 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 1.70071204 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 1.68964673 |
| 78 | Abnormality of the prostate (HP:0008775) | 1.68436041 |
| 79 | Testicular atrophy (HP:0000029) | 1.66869079 |
| 80 | Bladder diverticulum (HP:0000015) | 1.65894163 |
| 81 | Insomnia (HP:0100785) | 1.65175834 |
| 82 | Lymphoma (HP:0002665) | 1.64788835 |
| 83 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.61441230 |
| 84 | Abnormal protein glycosylation (HP:0012346) | 1.61006423 |
| 85 | Abnormal glycosylation (HP:0012345) | 1.61006423 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.61006423 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.61006423 |
| 88 | Verrucae (HP:0200043) | 1.59896304 |
| 89 | Papilloma (HP:0012740) | 1.59896304 |
| 90 | Abnormality of methionine metabolism (HP:0010901) | 1.59214361 |
| 91 | Restrictive lung disease (HP:0002091) | 1.58386297 |
| 92 | Skin rash (HP:0000988) | 1.56849870 |
| 93 | Hepatocellular necrosis (HP:0001404) | 1.54154586 |
| 94 | Aplastic anemia (HP:0001915) | 1.53490636 |
| 95 | Increased serum lactate (HP:0002151) | 1.52565203 |
| 96 | Increased IgM level (HP:0003496) | 1.52518849 |
| 97 | Basal cell carcinoma (HP:0002671) | 1.51942584 |
| 98 | Joint contractures involving the joints of the feet (HP:0100492) | 1.51238165 |
| 99 | Flexion contracture of toe (HP:0005830) | 1.51238165 |
| 100 | Recurrent pneumonia (HP:0006532) | 1.49493355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK1 | 4.30430025 |
| 2 | SMG1 | 3.94667803 |
| 3 | VRK2 | 3.87114566 |
| 4 | TLK1 | 3.67353309 |
| 5 | ZAK | 3.42997596 |
| 6 | NME2 | 2.86113018 |
| 7 | BCKDK | 2.45131848 |
| 8 | EEF2K | 2.35092325 |
| 9 | TESK2 | 2.26027012 |
| 10 | DAPK3 | 2.19078233 |
| 11 | TRIB3 | 2.07342882 |
| 12 | BUB1 | 2.06127872 |
| 13 | CDK12 | 2.01830199 |
| 14 | EPHA2 | 1.97777306 |
| 15 | BLK | 1.96612128 |
| 16 | KDR | 1.94177203 |
| 17 | AURKA | 1.91395063 |
| 18 | MAPKAPK3 | 1.89337237 |
| 19 | SCYL2 | 1.81043562 |
| 20 | RPS6KA5 | 1.69842775 |
| 21 | IRAK3 | 1.67501212 |
| 22 | MAP2K7 | 1.63365745 |
| 23 | CDC7 | 1.58535635 |
| 24 | TAF1 | 1.45791656 |
| 25 | ARAF | 1.45551037 |
| 26 | PAK4 | 1.45218286 |
| 27 | TRPM7 | 1.32951312 |
| 28 | MAP4K1 | 1.30519900 |
| 29 | RPS6KB2 | 1.27589876 |
| 30 | MOS | 1.21122242 |
| 31 | PKN2 | 1.16705617 |
| 32 | NEK1 | 1.16073202 |
| 33 | TBK1 | 1.09659407 |
| 34 | CDK7 | 1.03710965 |
| 35 | PASK | 1.03313109 |
| 36 | FGFR4 | 1.01393308 |
| 37 | DAPK1 | 1.00651537 |
| 38 | STK16 | 0.99105970 |
| 39 | AURKB | 0.98606346 |
| 40 | LMTK2 | 0.96873465 |
| 41 | EIF2AK3 | 0.95070569 |
| 42 | PIK3CG | 0.94797718 |
| 43 | TESK1 | 0.93789006 |
| 44 | CHEK2 | 0.92057848 |
| 45 | PIM2 | 0.90886048 |
| 46 | STK10 | 0.88892382 |
| 47 | MAP3K14 | 0.87944985 |
| 48 | MAPKAPK5 | 0.87733999 |
| 49 | ICK | 0.87687567 |
| 50 | ERBB4 | 0.86399427 |
| 51 | IRAK4 | 0.86071338 |
| 52 | MST1R | 0.84996250 |
| 53 | NEK9 | 0.83735502 |
| 54 | LIMK1 | 0.83510124 |
| 55 | MST4 | 0.83125858 |
| 56 | NUAK1 | 0.82672938 |
| 57 | MAPK11 | 0.79329109 |
| 58 | ERN1 | 0.77653049 |
| 59 | IKBKB | 0.76203506 |
| 60 | CDK9 | 0.75212826 |
| 61 | CDK19 | 0.74800813 |
| 62 | SYK | 0.74426817 |
| 63 | STK4 | 0.71489239 |
| 64 | MAP3K10 | 0.71024309 |
| 65 | HIPK2 | 0.69249228 |
| 66 | MAP3K13 | 0.65700604 |
| 67 | MAP3K8 | 0.65507520 |
| 68 | ATR | 0.63006776 |
| 69 | CSNK1G3 | 0.61721605 |
| 70 | CCNB1 | 0.61192456 |
| 71 | CDK4 | 0.61171937 |
| 72 | AKT2 | 0.59217861 |
| 73 | ILK | 0.59166011 |
| 74 | SRPK1 | 0.57020228 |
| 75 | IKBKE | 0.55984330 |
| 76 | BTK | 0.53565658 |
| 77 | EIF2AK2 | 0.51027520 |
| 78 | CDK8 | 0.50055492 |
| 79 | EPHB1 | 0.49620167 |
| 80 | CSNK1A1L | 0.48097792 |
| 81 | CSNK1G1 | 0.47319036 |
| 82 | MAP3K9 | 0.46697878 |
| 83 | TSSK6 | 0.44818838 |
| 84 | CSF1R | 0.44138543 |
| 85 | CHEK1 | 0.42913976 |
| 86 | MUSK | 0.42656105 |
| 87 | SIK1 | 0.42141583 |
| 88 | TXK | 0.42002038 |
| 89 | BRAF | 0.41820149 |
| 90 | MAP3K4 | 0.38410062 |
| 91 | PAK1 | 0.37948798 |
| 92 | PTK6 | 0.36790683 |
| 93 | KIT | 0.35327167 |
| 94 | MAP4K2 | 0.34701551 |
| 95 | MAPKAPK2 | 0.33077724 |
| 96 | GRK6 | 0.32388813 |
| 97 | LYN | 0.31792593 |
| 98 | JAK3 | 0.30516425 |
| 99 | RPS6KA4 | 0.27361422 |
| 100 | PBK | 0.27179514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 6.62340754 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 3.89849290 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.97542137 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.80145584 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.73601951 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.70830260 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65484409 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56248963 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50445579 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.30751363 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23187584 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.12104886 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03094259 |
| 14 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.96189105 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.91455041 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.89879953 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.87168428 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82459264 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.66957717 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.66684183 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64407927 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63785884 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.46523931 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.39512996 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.37175717 |
| 26 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36743000 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35995411 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28977640 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25231933 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23686464 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.22080637 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19529416 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14948992 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13626774 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.13125477 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03198372 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00334130 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98944552 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95351064 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89411343 |
| 41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88169716 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87307908 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86062651 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 0.84974218 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83824777 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81899067 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78055877 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76339106 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74104780 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.73505650 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72638112 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.72099692 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71458712 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67782210 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.65598508 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64978806 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64301917 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63624488 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62105557 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.61455262 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.61400109 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.61342612 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60960636 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.56577781 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50041757 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47524409 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46931416 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.46776283 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45539877 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41291470 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38948394 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36462647 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35443020 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.33134735 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31795903 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28641220 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27767068 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.27422165 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.25690573 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25431202 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.23846618 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21418268 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.20802081 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.19618398 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18950637 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18400842 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.18344268 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.18343992 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17492256 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16553069 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.16351045 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.12878601 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12566693 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11353968 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.10596866 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.10117420 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.09380793 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.07935646 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.07037215 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06910282 |

